Enantioselective determination of tramadol and its main phase I metabolites in human plasma by high-performance liquid chromatography

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 864, Issue 1-2, 2008, Pages 109-115

  Ardakani, Yalda H ^a   Mehvar, Reza ^b   Foroumadi, Alireza ^c   Rouini, Mohammad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AGP column; Enantioselective assay; Metabolite; Pharmacokinetics; Tramadol

Indexed keywords

ENANTIOSELECTIVE ASSAYS; PLASMA SAMPLES; SAMPLE PREPARATION;

ACETONITRILE; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITES; PHARMACOKINETICS;

PLASMA (HUMAN);

N DESMETHYLTRAMADOL; O NORTRAMADOL; TRAMADOL; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; DRUG HALF LIFE; DRUG STABILITY; ENANTIOMER; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLITE; PH; PRIORITY JOURNAL;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HUMANS; KINETICS; OROSOMUCOID; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY; STEREOISOMERISM; TRAMADOL;

EID: 40849102310     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2008.01.038     Document Type: Article

References (25)

1. Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., and Vaught J.L. J. Pharmacol. Exp. Ther. 260 1 (1992) 275
2. Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., Vaught J.L., Jacoby H.I., and Selve N. J. Pharmacol. Exp. Ther. 267 1 (1993) 331
3. Lee C.R., McTavish D., and Sorkin E.M. Drugs 46 2 (1993) 313
4. Paar W.D., Frankus P., and Dengler H.J. Clin. Investig. 70 8 (1992) 708
5. Liu H.C., Zhang X.J., Yang Y.Y., Wang N., and Hou Y.N. Acta Pharmacol. Sin. 23 1 (2002) 83
6. Liu H.C., Wang N., Liu C.S., Hu Y.Q., Liu J.F., and Hou Y.N. Acta Pharmacol. Sin. 22 10 (2001) 871
7. Rudaz S., Veuthey J.L., Desiderio C., and Fanali S. J. Chromatogr. A 846 1/2 (1999) 227
8. Campanero M.A., Garcia-Quetglas E., Sadaba B., and Azanza J.R. J. Chromatogr. A 1031 1/2 (2004) 219
9. Garcia Quetglas E., Azanza J.R., Cardenas E., Sadaba B., and Campanero M.A. Biopharm. Drug Dispos. 28 1 (2007) 19
10. Garcia-Quetglas E., Azanza J.R., Sadaba B., Munoz M.J., Gil I., and Campanero M.A. Pharmacol. Res. 55 2 (2007) 122
11. Kurth B., and Blaschke G.B. Electrophoresis 20 3 (1999) 555
12. Soetebeer U.B., Schierenberg M.O., Schulz H., Andresen P., and Blaschk G. J. Chromatogr. B: Biomed. Sci. Appl. 765 1 (2001) 3
13. Soetebeer U.B., Schierenberg M.O., Schulz H., Andresen P., and Blaschk G. J. Chromatogr. B: Biomed. Sci. Appl. 745 2 (2000) 271
14. Rudaz S., Cherkaoui S., Dayer P., Fanali S., and Veuthey J.L. J. Chromatogr. A. 868 2 (2000) 295
15. Ceccato A., Vanderbist F., Pabst J.Y., and Streel B. J. Chromatogr. B: Biomed. Sci. Appl. 748 1 (2000) 65
16. Mehvar R., Elliott K., Parasrampuria R., and Eradiri O. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 852 1/2 (2007) 152
17. Elsing B., and Blaschke G. J. Chromatogr. 612 2 (1993) 223
18. Ceccato P., Chiap P., Hubert J., and Crommen J. J Chromatogr B Biomed Sci Appl 698 1/2 (1997) 161
19. Campanero M.A., Calahorra B., Valle M., Troconiz I.F., and Honorato J. Chirality 11 4 (1999) 272
20. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER), 2001.
21. Öhman D., Norlander B., Peterson C., and Bengtsson F. J. Chromatogr. A 947 (2002) 247
22. Enquist M., and Hermansson J. J. Chromatogr. 519 (1990) 285
23. Kelly T., Doble P., and Dawson M. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 814 (2005) 315
24. Hermansson J. Trends Anal. Chem. 8 (1989) 251
25. Rouini M.R., Ardakani Y.H., Soltani F.K., Aboul-Enein H.Y., and Foroumadi A. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 830 (2006) 207